Yuhan Future Growth

Future criteria checks 2/6

Yuhan is forecast to grow earnings and revenue by 21.9% and 9.3% per annum respectively. EPS is expected to grow by 20.9% per annum. Return on equity is forecast to be 9.8% in 3 years.

Key information

21.9%

Earnings growth rate

20.9%

EPS growth rate

Pharmaceuticals earnings growth33.3%
Revenue growth rate9.3%
Future return on equity9.8%
Analyst coverage

Good

Last updated16 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

KOSE:A000105 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,485,917244,105253,780259,34616
12/31/20252,283,485195,043217,405222,30016
12/31/20242,095,987136,01591,122161,83111
9/30/20242,008,841165,686-93,59359,730N/A
6/30/20241,893,119147,849-75,289100,417N/A
3/31/20241,860,529124,466-80,670110,014N/A
12/31/20231,858,984133,993-59,775144,128N/A
9/30/20231,872,33688,109-59,302113,301N/A
6/30/20231,820,81176,045-94,82448,972N/A
3/31/20231,808,041101,446-18,662106,905N/A
12/31/20221,775,84795,144-2,35699,529N/A
9/30/20221,749,31574,66921,500112,004N/A
6/30/20221,769,24597,83664,662146,027N/A
3/31/20221,719,63097,911-77,1461,983N/A
12/31/20211,687,810102,58317,72699,000N/A
9/30/20211,725,26198,128-40,21463,556N/A
6/30/20211,703,47597,833-90,02816,218N/A
3/31/20211,685,62397,57833,086125,628N/A
12/31/20201,619,865192,761-55,85428,830N/A
9/30/20201,552,188184,730-12,07640,572N/A
6/30/20201,504,765168,66795,017136,587N/A
3/31/20201,448,677140,227-32,34912,995N/A
12/31/20191,480,35440,00619,25165,985N/A
9/30/20191,500,78244,23022,26271,414N/A
6/30/20191,497,13041,438-43,9551,332N/A
3/31/20191,523,95452,333109,427156,727N/A
12/31/20181,518,82357,48145,60293,452N/A
9/30/20181,481,90670,14654,109108,573N/A
6/30/20181,482,03484,572N/A107,587N/A
3/31/20181,450,870100,288N/A112,160N/A
12/31/20171,462,248109,034N/A126,125N/A
9/30/20171,434,749139,325N/A116,234N/A
6/30/20171,417,835137,434N/A135,085N/A
3/31/20171,395,518139,440N/A142,224N/A
12/31/20161,320,797161,249N/A74,144N/A
9/30/20161,274,011134,997N/A98,827N/A
6/30/20161,223,925155,819N/A97,292N/A
3/31/20161,163,130152,682N/A88,684N/A
12/31/20151,128,731126,047N/A126,235N/A
9/30/20151,097,229118,104N/A120,389N/A
6/30/20151,046,71698,362N/A140,058N/A
3/31/20151,031,87594,628N/A71,402N/A
12/31/20141,017,49290,948N/A94,386N/A
9/30/20141,007,10995,434N/A78,642N/A
6/30/2014970,25387,696N/A44,515N/A
3/31/2014953,19183,863N/A56,486N/A
12/31/2013943,60986,461N/A79,778N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A000105's forecast earnings growth (21.9% per year) is above the savings rate (2.7%).

Earnings vs Market: A000105's earnings (21.9% per year) are forecast to grow slower than the KR market (28.4% per year).

High Growth Earnings: A000105's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A000105's revenue (9.3% per year) is forecast to grow slower than the KR market (9.4% per year).

High Growth Revenue: A000105's revenue (9.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A000105's Return on Equity is forecast to be low in 3 years time (9.8%).


Discover growth companies